Wataru Kishimoto

1.4k total citations · 1 hit paper
29 papers, 953 citations indexed

About

Wataru Kishimoto is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Wataru Kishimoto has authored 29 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Pharmacology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Wataru Kishimoto's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Wataru Kishimoto is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Wataru Kishimoto collaborates with scholars based in Japan, Germany and Greece. Wataru Kishimoto's co-authors include Thomas Ebner, Eva Ludwig-Schwellinger, Olaf Schaefer, Asami Saito, Naoki Ishiguro, Naoki Ishiguro, Tae Inoue, Sumio Ohtsuki, Takashi Igarashi and Tetsuya Terasaki and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Endocrinology.

In The Last Decade

Wataru Kishimoto

27 papers receiving 937 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities

2011 357 citations Sumio Ohtsuki, Olaf Schaefer et al. Drug Metabolism and Disposition profile →

Peers

Wataru Kishimoto

ONCOL

PHARM

PPCH

EDM

Yannick Parmentier France

David A. Tess United States

Kenichi Umehara Switzerland

Chester Costales United States

Birk Poller Switzerland

Ernesto Callegari United States

Benjamin C. Lewis Australia

Jocelyn Yabut United States

Brian W. Ogilvie United States

Kazutomi Kusano Japan

Yannick Parmentier France

Wataru Kishimoto

583 ×1.3

ONCOL

335 ×0.8

PHARM

265 ×1.2

259 ×1.3

PPCH

72 ×0.7

EDM

Citations per year, relative to Wataru Kishimoto Wataru Kishimoto (= 1×) peers Yannick Parmentier

Countries citing papers authored by Wataru Kishimoto

Since Specialization

Citations

This map shows the geographic impact of Wataru Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Kishimoto more than expected).

Fields of papers citing papers by Wataru Kishimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Kishimoto. The network helps show where Wataru Kishimoto may publish in the future.

Co-authorship network of co-authors of Wataru Kishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Wataru Kishimoto. A scholar is included among the top collaborators of Wataru Kishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wataru Kishimoto. Wataru Kishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukami, Tatsuki, Naoki Ishiguro, Wataru Kishimoto, et al.. (2023). Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine. Drug Metabolism and Disposition. 51(12). 1569–1577. 5 indexed citations

Yamashita, Tomoki, et al.. (2023). Establishment of human intestinal organoids derived from commercially available cryopreserved intestinal epithelium and evaluation for pharmacokinetic study. Drug Metabolism and Pharmacokinetics. 54. 100532–100532. 5 indexed citations

Inui, Tatsuya, et al.. (2022). Establishment of MDR1-knockout human enteroids for pharmaceutical application. Drug Metabolism and Pharmacokinetics. 48. 100476–100476. 10 indexed citations

Ohgaki, Ryuichi, Chunhuan Jin, Minhui Xu, et al.. (2022). Functional coupling of organic anion transporter OAT10 (SLC22A13) and monocarboxylate transporter MCT1 (SLC16A1) influencing the transport function of OAT10. Journal of Pharmacological Sciences. 150(1). 41–48. 6 indexed citations

Inui, Tatsuya, et al.. (2022). Comparison of human biopsy-derived and human iPS cell-derived intestinal organoids established from a single individual. Drug Metabolism and Pharmacokinetics. 48. 100482–100482. 7 indexed citations

Yamashita, Tomoki, Tatsuya Inui, Kentaro Kawakami, et al.. (2021). Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research. Molecular Therapy — Methods & Clinical Development. 22. 263–278. 41 indexed citations

Yamashita, Tomoki, et al.. (2021). Comparison of culture media for human intestinal organoids from the viewpoint of pharmacokinetic studies. Biochemical and Biophysical Research Communications. 566. 115–122. 10 indexed citations

Takayama, Kazuo, Kohei Ito, Akiko Matsui, et al.. (2020). In Vivo Gene Expression Profile of Human Intestinal Epithelial Cells: From the Viewpoint of Drug Metabolism and Pharmacokinetics. Drug Metabolism and Disposition. 49(3). 221–232. 19 indexed citations

Nakanishi, Takeo, Hisakazu Komori, Xinying Wang, et al.. (2017). Different Involvement of OAT in Renal Disposition of Oral Anticoagulants Rivaroxaban, Dabigatran, and Apixaban. Journal of Pharmaceutical Sciences. 106(9). 2524–2534. 9 indexed citations

10.

Kishimoto, Wataru, Naoki Ishiguro, Eva Ludwig-Schwellinger, et al.. (2016). Usefulness of A Model-Based Approach for Estimating In Vitro P-Glycoprotein Inhibition Potency in a Transcellular Transport Assay. Journal of Pharmaceutical Sciences. 105(2). 891–896. 13 indexed citations

11.

Fuchs, Holger, Wataru Kishimoto, Dietmar Ganßer, P. Tanswell, & Naoki Ishiguro. (2014). Brain Penetration of WEB 2086 (Apafant) and Dantrolene in Mdr1a (P-Glycoprotein) and Bcrp Knockout Rats. Drug Metabolism and Disposition. 42(10). 1761–1765. 17 indexed citations

12.

Ishiguro, Naoki, et al.. (2013). Impact of Endogenous Esterase Activity on In Vitro P-Glycoprotein Profiling of Dabigatran Etexilate in Caco-2 Monolayers. Drug Metabolism and Disposition. 42(2). 250–256. 42 indexed citations

13.

Kishimoto, Wataru, Naoki Ishiguro, Eva Ludwig-Schwellinger, Thomas Ebner, & Olaf Schaefer. (2013). In Vitro Predictability of Drug-Drug Interaction Likelihood of P-Glycoprotein-Mediated Efflux of Dabigatran Etexilate Based on [I]2/IC50 Threshold. Drug Metabolism and Disposition. 42(2). 257–263. 47 indexed citations

14.

Ishiguro, Naoki, Hidetada Shimizu, Wataru Kishimoto, Thomas Ebner, & Olaf Schaefer. (2012). Evaluation and Prediction of Potential Drug-Drug Interactions of Linagliptin Using In Vitro Cell Culture Methods. Drug Metabolism and Disposition. 41(1). 149–158. 24 indexed citations

15.

Ohtsuki, Sumio, Olaf Schaefer, Hirotaka Kawakami, et al.. (2011). Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities. Drug Metabolism and Disposition. 40(1). 83–92. 357 indexed citations breakdown →

16.

Ishiguro, Naoki, Kazuya Maeda, Asami Saito, et al.. (2008). Establishment of a Set of Double Transfectants Coexpressing Organic Anion Transporting Polypeptide 1B3 and Hepatic Efflux Transporters for the Characterization of the Hepatobiliary Transport of Telmisartan Acylglucuronide. Drug Metabolism and Disposition. 36(4). 796–805. 60 indexed citations

17.

Ishiguro, Naoki, Takashi Nozawa, Asami Saito, et al.. (2004). INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER. Drug Metabolism and Disposition. 32(5). 519–524. 21 indexed citations

18.

Kishimoto, Wataru, Toyoko Hiroi, Mayuko Osada, et al.. (2003). Cytochrome P450 2D Catalyze Steroid 21-Hydroxylation in the Brain. Endocrinology. 145(2). 699–705. 71 indexed citations

19.

Kishimoto, Wataru, et al.. (2000). Quantitative Prediction of in Vivo Drug Interactions between Nevirapine and Antifungal Agents from in Vitro Data in Rats.. Biological and Pharmaceutical Bulletin. 23(9). 1027–1032. 10 indexed citations

20.

Kishimoto, Wataru, et al.. (1997). Identification of human cytochrome P450 isoforms involved in the metabolism of brotizolam. Xenobiotica. 27(9). 913–922. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact